Catalog# |
Product Description |
Product Type |
Size |
200-200-HAH |
Human Anti-Human
IgG (HAHA) ELISA kit, 96 tests |
Kit |
1 kit |
200-205-HAM |
Human Anti-Mouse
IgG (HAMA) ELISA kit, 96 tests |
Kit |
1 kit |
200-210-RAG |
Rituximab/Rituxan/Anti-CD20
(Active) ELISA Kit (Human/mouse/rat),96 tests |
Kit |
1 kit |
200-245-HAM |
Human
Anti-Rituximab/Rituxan (HADA/HAMA) IgG ELISA kit for human, 96 tests |
Kit |
1 kit |
200-300-ADG |
Humira/Adalimumab
(Human Anti-TNF-alpha) ELISA Kit for dog, 96 tests |
Kit |
1 kit |
200-310-AHG |
Humira/Adalimumab
(Human Anti-TNF-alpha) ELISA Kit for human, 96 tests |
Kit |
1 kit |
200-320-ADG |
Human
Anti-Humira/Adalimumab (Human Anti-TNF-alpha) IgG ELISA Kit, 96 tests |
Kit |
1 kit |
200-320-AHG |
Human
Anti-Humira/Adalimumab (Human Anti-TNF-alpha) ELISA Kit for human, 96 tests |
Kit |
1 kit |
200-330-TNF |
Human TNF-alpha
ELISA Kit, 96 tests |
Kit |
1 kit |
CD20-141-R |
Recombinant
Human CD20/MS4A1-mFC fusion Protein (141-184, 44-aa, ECD, rituximab-binding peptide) |
Recombinant
protein |
20 ug |
CD20-142-P |
Human CD20/MS4A1
linear peptide (142-184, 43-aa, extracellular domain) rituximab-binding peptide, >95% pure |
peptide |
100 ug |
CD20-145-R |
Recombinant (HEK
cells) purified human CD20/MS4A1 (213-297 aa) his tag Protein |
Recombinant
protein |
20 ug |
CD20-146-R |
Recombinant (HEK
cells) human CD20/MS4A1 (141-184 aa) hFc- fusion Protein |
Recombinant
protein |
10 ug |
CD20-147-R |
Recombinant (HEK
cells) purified Ferrret CD20/MS4A1 (213-297 aa) his tag Protein |
Recombinant
protein |
10 ug |
CD20-165-P |
human CD20/MS4A1
linear peptide (165-184, 20-aa, extracellular domain) broad reactivity with CD20-specific antibodies |
peptide |
100 ug |
CD20-1731-P |
Human CD20/MS4A1
peptide (Acetyl-cPYaNPSLc, 9-aa, Cyclic Cys1-Cys9);
contains ANPS motif and reactivity with Rituximab |
cyclic peptide |
100 ug |
CD20-1732-P |
Human CD20/MS4A1
cylcic peptide (Acetyl-cWAANPSMAc, 11 aa, Cys1-Cys11);
contains the ANPS motif and avidity for rituximab |
cyclic peptide |
100 ug |
CD20-1733-P |
Human CD20/MS4A1
cyclic peptide (Acetyl-cPYsNPSLc; 9aa, Cys1-Cys9;
contains NPS motif and react with rituximab |
cyclic peptide |
100 ug |
CD20-182-P |
Human CD20/MS4A1
linear peptide (CWWEWTIGC, 9-aa) contains motif WEWTI
of human CD-20 for rtiuximab |
peptide |
100 ug |
CD20-21-M |
Monoclonal
Anti-Human CD20/MS4A1 peptide (EC-domain, rituximab binding) ascites |
Antibodies |
100 ul |
CD20-22-A |
Anti-Human
CD20/MS4A1 peptide (EC-domain, rituximab binding domain) IgG, aff pure |
Antibodies |
100 ul |
CD20-22-P |
Anti-Human
CD20/MS4A1 control/blocking peptide (EC-domain, rituximab binding domain) |
Antibodies |
100 ug |
CD20-23-M |
Humanized
(chimeric) Anti-Human CD20/MS4A1 IgG (rituximab biosimilar), pure |
Antibodies |
100 ul |
CD20-RP1L-P |
CD20/MS4A1
linear peptide (WPRWLEN, 7-aa) contains motif WPXWLE, 6-aa; Rp1L-1) and reacts with rituximab |
peptide |
100 ug |
CD20-RP5L-P |
CD20/MS4A1
linear peptide (QDKLTQWPKWLEg, 13-aa) contains WPXWLE motif and reacts with rituximab |
peptide |
100 ug |
CD20F-100 |
Anti-Human
CD20-FITC conjugate |
Antibodies |
100 Tests |
CD20P-100 |
Anti-Human
CD20-PE conjugate |
Antibodies |
100 Tests |
CD20PC-100 |
Anti-Human
CD20-PE-Cy5-conjugate |
Antibodies |
100 Tests |
CD20UL-100 |
Anti-Human CD20
IgG, Unlabeled |
Antibodies |
100 ug |
RP-340 |
Recombinant
Anti-Human CD20 Antibody IgG |
Antibodies |
50 ug |
RP1L-P |
CD20/MS4A1
linear peptide (WPRWLEN, 7-aa) contains motif WPXWLE, 6-aa; Rp1L-1) and reacts with rituximab |
peptide |
100 ug |
RP5L-P |
CD20/MS4A1
linear peptide (QDKLTQWPKWLEg, 13-aa) contains WPXWLE motif and reacts with rituximab |
peptide |
100 ug |